Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 1, 2007, Pages 122-124

  Bouyer, Sabrina ^a   Imbert, Christine ^a,b   Daniault, Gyslaine ^a   Cateau, Estelle ^a   Rodier, Marie Hélène ^a,b  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE POITIERS   (France)

Author keywords

Acanthameba castellanii; Acanthamoeba culbertsoni; Acanthamoeba polyphaga; Keratitis

Indexed keywords

CASPOFUNGIN; TOLONIUM CHLORIDE;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA CULBERTSONI; ACANTHAMOEBA POLYPHAGA; ANTIBIOTIC SENSITIVITY; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CYST (RESTING STAGE); DRUG EFFICACY; GROWTH INHIBITION; IN VITRO STUDY; INCUBATION TIME; NONHUMAN; PARASITE VIABILITY; TROPHOZOITE;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ANIMALS; PEPTIDES, CYCLIC; TROPHOZOITES;

EID: 33845896779     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl451     Document Type: Article

References (11)

1. Cabral G, Marciano-Cabral F. Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 2003; 16: 273-307.
2. Niederkorn JY, Alizadeh H, Leher H et al. The pathogenesis of Acanthamoeba keratitis. Microbes Infect 1999; 1: 437-43.
3. Schuster FL, Visvesvara GS. Opportunistic amoebae: Challenges in prophylaxis and treatment. Drug Resist Updat 2004; 7: 41-51.
4. Singhal T, Bajpai A, Kalra V et al. Successful treatment of disseminated Acanthamoeba infection in an immunocompromised patient. Pediatr Infect Dis J 2001; 20: 623-7.
5. Seijo Martinez M, Gonzalez-Mediero G, Santiago P et al. Granulomatous amebic encephalitis in a patient with AIDS: Isolation of Acanthamoeba sp. group II from brain tissue and successful treatment with sulfadiazine and fluconazole. J Clin Microbiol 2000; 38: 3892-5.
6. Walochnik J, Duchêne M, Seifert K et al. Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrob Agents Chemother 2002; 46: 695-701.
7. Schuster FL. Cultivation of pathogenic and opportunistic free-living amoeba. Clin Microbiol Rev 2002; 15: 342-54.
8. Goldblum D, Fruesh BE, Sarra GM et al. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 2005; 49: 1359-63.
9. Denning DW. Echinocandins: A new class of antifungal. J Antimicrob Chemother 2002; 49: 889-91.
10. Kumar R, Lloyd D. Recent advances in the treatment of Acanthamoeba keratitis. Clin Inf Dis 2002; 35: 434-41.
11. Mattana A, Biancu G, Alberti L et al. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii. Antimicrob Agents Chemother 2004; 48: 4520-7.